Atlas FDA

VITALITY AVT, model A135 and model A155. Implantable Cardioverter Defibrillator. Atrial and Ventricular Therapies. Steri

FDA device recall Z-0955-05 · posted 2005-06-30 · Terminated

Recall details

Recalling firm
Boston Scientific CRM Corp
Reason for recall
The atrial therapy (AVT) subgroups of certain Guidant ICD and CRT-D product families are subject to a condition in which a random memory error causes functional 'latching' that limits available therapy.
Action taken
Firm issued a Dr. Doctor letter dated 06/17/05. Letter informs physicians of the issue, clinical implications, recommendations and action taken by the firm.
Root cause
Other
Status
Terminated
Product code
LWP
Quantity affected
22,575 devices (19,446 implanted world wide)
Distribution
worldwide. To the US and OUS countries to include: Argentina, Australia, Austria, Belgium, Canada, Chile, Cyprus, Denmark, France, Germany, Guadeloupe, Hong Kong, Ireland, Israel, Italy, Japan, Jordan
Date initiated
2005-06-17
Date posted
2005-06-30
Date terminated
2008-03-02
Location
Saint Paul, MN

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.